retatrutide phase 2 results 2024 2025 hits 28% weight loss in 3 Want to learn more about
Description
Nausea Nausea is one of the most common side effects of retatrutide
It enhances the utilization of carbohydrates as a fuel source while sparing fat, reduces lipid oxidation, and increases lipogenesis
However, compounded GLP-1 products are not FDA-approved as finished products, may differ in formulation, and should not be treated as equivalent to Ozempic, Wegovy, Mounjaro, or Zepbound
Cummings and Dr
Activating both pathways simultaneously produces a synergistic GH response significantly greater than either peptide alone
